More drops for Nvidia and other AI stocks drag the US market lower

The U.S. market declined on Monday, led by a 2.4% drop in Nvidia, following CEO Jensen Huang's resignation. The S&P 500 fell 0.9%, and the Nasdaq dropped 1.5%. Other AI-related stocks like Broadcom and AMD also fell. Nvidia is set to report quarterly results on Tuesday. L3Harris and Summit Therapeutics also saw declines, while Tyson Foods rose 7.2% after reporting stronger-than-expected profits.

Original reporting
Published Nov 16, 2026, 1:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 3:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$NVDA
Bearish
high confidence
Mentioned
$NVDA · $AVGO · $AMD · $CRWV · $GEV · $LHX
Relevance
7/10
AlphAI data visualization · based on reporterherald.com
Decision brief

The 30-second read

$NVDABearishMed
01

Why it matters

The dominant tradable thread is cross-asset risk repricing around AI leadership uncertainty and potential policy restrictions on data-center construction, with company-specific catalysts for L3Harris (FAA ground-stop allegation) and Summit Therapeutics (FDA indicated non-approvability).

02

Market read

Traders can use this as a high-correlation risk-off signal for AI-related equities into Nvidia’s next earnings, while also isolating idiosyncratic catalysts in L3Harris and Summit Therapeutics.

03

What to watch

The article also flags macro drivers (Treasury yields easing, Brent down) that could partially offset AI-specific pessimism if risk appetite improves into Nvidia’s print.

Relevance 7/10Novelty 5/10Timing: ahead of Nvidia’s earnings and interim CEO Colette Kress remarks scheduled for Tuesday

Background

The piece frames Monday’s decline as an AI-industry sentiment reset, starting with Nvidia after Jensen Huang’s resignation, and broad read-through into chips, cloud compute, and AI data-center power equipment.

Company-level read

Ticker impact

$NVDABearishHigh confidence
Context

Nvidia shares sank 2.4% as the article links the selloff to Jensen Huang’s resignation and upcoming quarterly results and CEO remarks.

Expected impact

Likely pressure as investors reprice AI leadership continuity and await the next quarterly results and guidance framing.

Evidence & confidence

The article explicitly ties the heaviest Wall Street weight to Huang’s resignation and flags Nvidia’s earnings and interim CEO speech as the next catalyst.

$AVGOBearishMedium confidence
Context

Broadcom dropped 5.1% in sympathy with AI-stock weakness, with the article citing concerns about the broader industry.

Expected impact

Likely further downside or elevated volatility if AI-industry fears persist after Nvidia’s leadership shock.

Evidence & confidence

The move is described as driven by broader AI-industry concerns rather than a Broadcom-specific disclosure.

$AMDBearishMedium confidence
Context

Advanced Micro Devices fell 4% as the article says it had climbed earlier on hopes of competitive advantage but then reversed with Nvidia.

Expected impact

Likely downside bias while investors reassess the durability of AI chip share gains.

Evidence & confidence

The article frames AMD’s move as read-through from Nvidia and AI-industry sentiment, not a new AMD-specific event.

$CRWVBearishMedium confidence
Context

CoreWeave sank 5.2% after the article describes it as renting access to Nvidia chips over the cloud, making it sensitive to Nvidia-driven sentiment.

Expected impact

Likely pressure as investors price higher uncertainty for AI compute demand and Nvidia-linked supply economics.

Evidence & confidence

The article provides a direct business linkage (buys Nvidia chips, rents access) but no CoreWeave-specific fundamental update.

$GEVBearishLow confidence
Context

GE Vernova slipped 1.5% as the article links it to helping power AI data centers, making it another AI-infrastructure sentiment proxy.

Expected impact

Likely modest downside or underperformance if the market expects slower AI data-center buildouts.

Evidence & confidence

The article mentions GE Vernova’s move and AI data-center linkage, but provides no company-specific catalyst.

$LHXBearishMedium confidence
Context

L3Harris Technologies fell 2.2% after the article says administration officials suggested it may be at fault for a nationwide FAA ground stop.

Expected impact

Likely continued downside risk until the investigation clarifies responsibility and any remediation actions.

Evidence & confidence

This is a concrete, named event with a stated allegation, though the article notes L3Harris is supporting the FAA investigation.

$SMMTBearishHigh confidence
Context

Summit Therapeutics sank 6.5% after the article says the FDA indicated it cannot approve its lung-cancer therapy application.

Expected impact

Likely further downside or high volatility as investors digest the FDA feedback and anticipate next regulatory steps.

Evidence & confidence

The article reports an FDA approval obstacle as the direct driver of the stock move.

$TSNBullishMedium confidence
Context

Tyson Foods rose 7.2% after reporting stronger-than-expected profit but weaker-than-expected revenue due to selling less beef.

Expected impact

Likely support from profit beat, with upside tempered by the revenue miss and demand/volume concerns.

Evidence & confidence

The article provides both the positive profit surprise and the negative revenue/volume detail as the driver of the move.

Market effects

AI chip and AI-infrastructure proxies are trading as a basket on leadership and data-center restriction fears, increasing correlation and volatility.

Europe and Asia are mixed, with South Korea and Japan down sharply on weakness in tech and AI-related stocks.

Higher-for-longer rate sensitivity is reinforced by easing Treasury yields tied to oil’s drop, influencing discount rates for growth/AI equities.

Counterpoint

The Nvidia leadership shock may be more about optics than fundamentals, and the upcoming earnings could re-anchor expectations if guidance remains strong.

Key entities

  • Nvidia

    AI chip leader whose leadership change is cited as a key driver of the sector selloff and whose earnings are due Tuesday.

  • CoreWeave

    Cloud compute provider described as buying Nvidia chips and renting access, making it sensitive to Nvidia-linked AI demand expectations.

  • L3Harris Technologies

    FAA contractor flagged by administration officials in connection with a nationwide ground stop investigation.

  • Summit Therapeutics

    Biopharma company whose FDA feedback indicates it cannot approve its lung-cancer therapy application.

  • Tyson Foods

    Consumer/industrial bellwether that rose on a profit beat but faced a revenue miss tied to lower beef sales.

Related articles

$CGONMed

Biotech's Monday Split: Two Trial Wins, One Trial Miss and an FDA Rejection

Biotech stocks moved amid clinical and regulatory news. CG Oncology's bladder cancer drug met its primary endpoint, reducing recurrence risk by 68%. Lexeo's gene therapy showed promising interim data. Summit Therapeutics' lung cancer drug received an FDA rejection, and Aclaris' atopic dermatitis treatment missed Phase 2 goals. The S&P 500 and Nasdaq fell 1.92% and 2.49%, respectively, according to CNBC.

$NVDAMed

US Pulls the Cloud Into Its AI Chip Fight With China

The U.S. Department of Commerce issued a rule requiring licenses for exporting advanced AI chips to data centers supplying Chinese firms, citing cybersecurity and military risks. The rule targets overseas data centers and extends to certain countries, exempting U.S.-headquartered customers with reporting. It replaces the Biden-era AI diffusion framework and takes effect upon publication in the Federal Register.

SK hynix Nvidia Sales Double to 35 Trillion Won on HBM4 Ramp

SK hynix reported 35 trillion won ($24 billion) in revenue from Nvidia in Q1-Q3 2023, double the prior year's figure. The increase is attributed to HBM4 memory shipments for Nvidia's AI chips. Nvidia's share of SK hynix's total revenue was 14.79%, down from 26.98% in 2022. SK hynix also saw significant revenue growth from the U.S. and China, and increased R&D and capital expenditure.

$TSNMed

Tyson Foods, Inc. Q4 2026 Earnings Call Summary

Tyson Foods reported Q4 2026 earnings, with strong performance in Prepared Foods and Chicken offsetting Beef segment losses. The company plans to shift to a 'commercially led, operations enabled' framework and invest in AI, robotics, and plant efficiency. FY27 guidance anticipates a 3.5% to 5.5% sales decline, driven by lower Beef volumes, while Chicken and Prepared Foods segments are expected to grow 3% to 4%.

$NVDAMed

New US rules aim to close loophole, restrict Chinese firms’ remote access to AI servers and infrastructure — seeks to combat cloud rental workarounds to export controls

The U.S. Commerce Department's BIS issued a rule to prevent non-whitelisted countries from accessing advanced AI hardware via cloud workarounds, targeting companies like Nvidia. The rule requires overseas data centers to restrict access to U.S. technology and imposes licensing requirements for exports to certain countries. It aims to close loopholes in existing export controls, with enforcement beginning in 90 days.

$SMMTHighAI 9/10

Summit Therapeutics Sinks on FDA Rejection

Summit Therapeutics (SMMT) shares fell 16.5% after the FDA rejected its lung cancer drug ivonescimab, citing insufficient evidence of overall survival benefit. The company plans to continue development, but no resubmission timeline was provided. Summit's stock closed at $11.82, its lowest since August. The FDA's decision follows positive progression-free survival results but insufficient overall survival data.